Antonella Mannini Selected Research

Breast Neoplasms (Breast Cancer)

1/2021

Establishment and characterization of a new spontaneously immortalized ER-/PR-/HER2+ human breast cancer cell line, DHSF-BR16.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Antonella Mannini Research Topics

Disease

11	Neoplasms (Cancer) 01/2022 - 01/2005
6	Melanoma (Melanoma, Malignant) 01/2022 - 01/2006
4	Experimental Melanoma 03/2009 - 01/2002
2	Neoplasm Metastasis (Metastasis) 10/2009 - 01/2006
1	Breast Neoplasms (Breast Cancer) 01/2021
1	Lymphoma (Lymphomas) 10/2009
1	Cachexia 10/2009
1	Carcinogenesis 03/2009

Drug/Important Bio-Agent (IBA)

2	Biomarkers (Surrogate Marker)IBA 01/2021 - 06/2007
2	Fish OilsIBA 10/2009 - 03/2009
2	Omega-3 Fatty Acids (Omega 3 Fatty Acids)IBA 10/2009 - 03/2009
2	CytokinesIBA 01/2008 - 12/2006
2	matrigelIBA 01/2008 - 12/2006
1	Tryptophan Oxygenase (Tryptophan 2,3 Dioxygenase)IBA 01/2022
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2022
1	tariquidar (XR9576)IBA 02/2021
1	ChloridesIBA 02/2021
1	BerberineIBA 02/2021
1	Antineoplastic Agents (Antineoplastics)IBA 02/2021
1	SolutionsIBA 01/2018
1	Pyruvic Acid (Pyruvate)IBA 01/2018
1	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 10/2009
1	Corn Oil (Oil, Corn)IBA 10/2009
1	Conditioned Culture MediaIBA 01/2008
1	Urokinase-Type Plasminogen Activator (Urokinase)FDA Link 01/2008
1	EnzymesIBA 01/2008
1	Monoclonal AntibodiesIBA 01/2008
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2008
1	Peptide Hydrolases (Proteases)FDA Link 01/2008
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2008
1	Platelet Activating FactorIBA 12/2006
1	Protein Kinase CIBA 01/2006
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2006
1	Essential Fatty AcidsIBA 01/2006
1	Lipoxygenase (Lipoxygenase-1)IBA 06/2005
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 01/2005
1	Histocompatibility Antigens Class IIBA 01/2002

Therapy/Procedure

1	Neoadjuvant Therapy 01/2021
1	Adjuvant Chemotherapy 01/2021
1	Therapeutics 10/2015